Biotransformation reactions of five-membered aromatic heterocyclic rings

被引：462

作者：

Dalvie, DK

Kalgutkar, AS

Khojasteh-Bakht, SC

Obach, RS

O'Donnell, JP

机构：

[1] Pfizer Inc, Global Res & Dev, Pharmacokinet Dynam & Drug Metab, Groton, CT 06340 USA

[2] Genentech Inc, Small Mol Pharmacol, San Francisco, CA 94080 USA

来源：

CHEMICAL RESEARCH IN TOXICOLOGY | 2002年 / 15卷 / 03期

关键词：

D O I：

10.1021/tx015574b

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

[No abstract available]

引用

页码：269 / 299

页数：31

共 279 条

[1]

Äbelö A, 2000, DRUG METAB DISPOS, V28, P58

[2]

Ahmed S, 1995, Drug Des Discov, V13, P27

[3]

ALLEN J G, 1971, Xenobiotica, V1, P3

[4]

Ashby J, 1984, COMPREHENSIVE HETERO, V1, P111

[5] METABOLIC OXIDATION OF THE PYRROLE RING - STRUCTURE AND ORIGIN OF SOME URINARY METABOLITES OF THE ANTIHYPERTENSIVE PYRROLYLPYRIDAZINAMINE, MOPIDRALAZINE .3. STUDIES WITH THE C-13-LABELED DRUG [J].

ASSANDRI, A ;

TARZIA, G ;

BELLASIO, E ;

CIABATTI, R ;

TUAN, G ;

FERRARI, P ;

ZERILLI, L ;

LANFRANCHI, M ;

PELIZZI, G .

XENOBIOTICA, 1987, 17 (05) :559-573

[6]

ASSANDRI A, 1985, XENOBIOTICA, V15, P1089, DOI 10.3109/00498258509049103

[7] METABOLIC PATHWAYS OF THE ANTI-HYPERTENSIVE AGENT, N-(2,5-DIMETHYL-1H-PYRROL-1-YL)-6-(4-MORPHOLINYL)-3-PYRIDAZINAMINE HYDROCHLORIDE .1. STUDIES IN THE RAT [J].

ASSANDRI, A ;

PERAZZI, A ;

BALDOLI, E ;

FERRARI, P ;

RIPAMONTI, A ;

BELLASIO, E ;

TUAN, G ;

ZERILLI, LF ;

TARZIA, G .

XENOBIOTICA, 1985, 15 (12) :1069-1087

[8]

ASSANDRI A, 1984, DRUG METAB DISPOS, V12, P257

[9] 1,2,3-Thiadiazole: A novel heterocyclic heme ligand for the design of cytochrome P450 inhibitors [J].

Babu, BR ;

Vaz, ADN .

BIOCHEMISTRY, 1997, 36 (23) :7209-7216

[10] Adverse effects of thyroid hormone preparations and antithyroid drugs [J].

Bartalena, L ;

Bognzzi, F ;

Martino, E .

DRUG SAFETY, 1996, 15 (01) :53-63

← 1 2 3 4 5 6 7 8 9 10 →